John D Mcghee
Friday, 20 February 2015
Bayer diabetes business sale not imminent: sources
FRANKFURT (Reuters) - German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment